|
1
|
Libby P: Inflammation in atherosclerosis.
Nature. 420:868–874. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Miller GJ and Miller NE:
Plasma-high-density-lipoprotein concentration and development of
ischaemic heart-disease. Lancet. 1:16–19. 1975. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hausenloy DJ and Yellon DM: Targeting
residual cardiovascular risk: Raising high-density lipoprotein
cholesterol levels. Heart. 94:706–714. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Duong PT, Collins HL, Nickel M, Lund-Katz
S, Rothblat GH and Phillips MC: Characterization of nascent HDL
particles and microparticles formed by ABCA1-mediated efflux of
cellular lipids to apoA-I. J Lipid Res. 47:832–843. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abd El-Aziz TA, Mohamed RH and Hagrass HA:
Increased risk of premature coronary artery disease in egyptians
with ABCA1 (R219K), CETP (TaqIB), and LCAT (4886C/T) genes
polymorphism. J Clin Lipidol. 8:381–389. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koopal C, Visseren FL, Kastelein JJ and
Westerink J: Premature atherosclerosis, extremely low
HDL-cholesterol and concurrent defects in APOA1 and ABCA1 genes: A
family case report. Int J Cardiol. 177:e19–e21. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lv YC, Tang YY, Peng J, Zhao GJ, Yang J,
Yao F, Ouyang XP, He PP, Xie W, Tan YL, et al: MicroRNA-19b
promotes macrophage cholesterol accumulation and aortic
atherosclerosis by targeting ATP-binding cassette transporter A1.
Atherosclerosis. 236:215–226. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu Y, Liu Q, Xu Y, Liu C, Wang X, He X,
Zhu N, Liu J, Wu Y, Li Y, et al: Rutaecarpine suppresses
atherosclerosis in ApoE-/- mice through upregulating ABCA1 and
SR-BI within RCT. J Lipid Res. 55:1634–1647. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maegdefessel L: The emerging role of
microRNAs in cardiovascular disease. J Intern Med. 276:633–644.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fichtlscherer S, De Rosa S, Fox H,
Schwietz T, Fischer A, Liebetrau C, Weber M, Hamm CW, Röxe T,
Müller-Ardogan M, et al: Circulating microRNAs in patients with
coronary artery disease. Circ Res. 107:677–684. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chistiakov DA, Orekhov AN and Bobryshev
YV: Cardiac extracellular vesicles in normal and infarcted heart.
Int J Mol Sci. 17(pii): E632016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Huber HJ and Holvoet P: Exosomes: Emerging
roles in communication between blood cells and vascular tissues
during atherosclerosis. Curr Opin Lipidol. 26:412–419. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sayed AS, Xia K, Li F, Deng X, Salma U, Li
T, Deng H, Yang D, Haoyang Z, Yang T and Peng J: The diagnostic
value of circulating microRNAs for middle-aged (40-60-year-old)
coronary artery disease patients. Clinics (Sao Paulo). 70:257–263.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Niculescu LS, Simionescu N, Sanda GM,
Carnuta MG, Stancu CS, Popescu AC, Popescu MR, Vlad A, Dimulescu
DR, Simionescu M and Sima AV: MiR-486 and miR-92a identified in
circulating HDL discriminate between stable and vulnerable coronary
artery disease patients. PLoS One. 10:e01409582015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang T, Tian F, Wang J, Jing J, Zhou SS
and Chen YD: Endothelial cell autophagy in atherosclerosis is
regulated by miR-30-mediated translational control of ATG6. Cell
Physiol Biochem. 37:1369–1378. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Suzuki E, Fujita D, Takahashi M, Oba S and
Nishimatsu H: Stem cell-derived exosomes as a therapeutic tool for
cardiovascular disease. World J Stem Cells. 8:297–305. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Raitoharju E, Oksala N and Lehtimäki T:
MicroRNAs in the atherosclerotic plaque. Clin Chem. 59:1708–1721.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Narahari A, Hussain M and Sreeram V:
MicroRNAs as biomarkers for psychiatric conditions: A review of
current research. Innov Clin Neurosci. 14:53–55. 2017.PubMed/NCBI
|
|
19
|
Schumacher T and Benndorf RA: ABC
transport proteins in cardiovascular disease-A brief summary.
Molecules. 22(pii): E5892017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Rotllan N, Price N, Pati P, Goedeke L and
Fernández-Hernando C: microRNAs in lipoprotein metabolism and
cardiometabolic disorders. Atherosclerosis. 246:352–360. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yang Z, Cappello T and Wang L: Emerging
role of microRNAs in lipid metabolism. Acta Pharm Sin B. 5:145–150.
2015. View Article : Google Scholar : PubMed/NCBI
|
